Hansen-Pupp, Ingrid <br/><br/>
Continuous longitudinal infusion of rhIGF-1/rhIGFBP-3 in extremely preterm infants: Evaluation of feasibility in a phase II study.  [electronic resource] 

 -  Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society  10 2017 
 - 44-51 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1532-2238 
<br/><br/><label>Standard No.: </label>10.1016/j.ghir.2017.08.004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Blood Glucose--analysis<br/>Feasibility Studies<br/>Female<br/>Gestational Age<br/>Humans<br/>Infant<br/>Infant, Extremely Premature--physiology<br/>Infant, Newborn<br/>Insulin-Like Growth Factor Binding Protein 3--administration & dosage<br/>Insulin-Like Growth Factor I--administration & dosage<br/>Longitudinal Studies<br/>Male<br/>Recombinant Proteins--administration & dosage<br/>Retinopathy of Prematurity--prevention & control